Approximately 20,000 treatment materials are managed in accordance with the national standard codes and are used economically.
Management involves classifying of the items, assigning of codes based on their purpose and function, and setting appropriate pricing criteria.
Device fee reimbursement listing stands for the process of receiving approval for legitimate distribution and sales of medical devices from the
'Ministry of Health and Welfare based on the 'National Health Insurance Act' through a prescribed application.
Highest price/standard price/non-reimbursement/ selective reimbursement listing. Actions for cost investigation and re-evaluation.
Organization: Health Insurance Review & Assessment Service
Link: http://www.hira.or.kr/eng/main.do
When a healthcare provider applies for the insurance of medical practices deemed safe and effective,
the Health Insurance Review Committee will evaluate the possibility of replacement,
cost, and effectiveness to decide eligibility to receive insurance benefits and its pricing if eligible under the criteria.
Decision is made for insurance coverage and pricing. Set salary criteria and re-evaluation of its relative value.
Organization: Health Insurance Review & Assessment Service
Link:http://www.hira.or.kr/eng/main.do
The targeted fields of health technology assessment in Korea are internal medicine, surgical operations, and other associated tests.
Assessment areas are divided into 'safety and effectiveness assessments', pursuant to the Medical Services Act, 'suitability of benefits and cost-effectiveness assessments', pursuant to the National Health Insurance Act.
Organization: Center for New Health Technology Assessment, nHTA
Link: https://nhta.neca.re.kr/nhta/main/
nhtaENG0000.ecg
